Nora Chokr
@NChokr
Followers
237
Following
338
Media
5
Statuses
158
Bone Marrow Transplant MD| Cellular Therapy | Hematology & Oncology @weillcornell @nyphospital @AUBMC_official alum
New York, USA
Joined September 2010
RT @christinemphmd: Congrats Drs. Evelyn Orlando & Herman van Besien for participating in the @lymphoma Lymphoma Scientific Research Mentor….
0
4
0
RT @WeillCornellBMT: Drs. Alexandra Gomez (@AGomez_MD) and Nora Chokr (@NChokr)’s article on the impact of disparities in access to #StemCe….
nature.com
0
2
0
RT @WeillCornellBMT: Applications for the 2026 @WeillCornell @nyphospital advanced Bone Marrow Transplant (#BMT) and #CellularTherapy fello….
0
8
0
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
348
132
2K
RT @christinemphmd: Thanks @nyphospital for a fun night on Broadway for @leftontenthplay. Wonderful to see our @WCMLeukemia team highlighte….
0
5
0
RT @Razan_Mohty: Dr @Mohty_EBMT elegantly discussing the complex question of donor choice. 👇check the summary slide. #ASH24 #ASH24rm @AS….
0
19
0
RT @samyamshon: Dr @CaitieGribbinMD presented incredibly data on the role of follicular dendritic cells and the temporal relationship with….
0
7
0
RT @DrHKantarjian: MRD is highly prognostic in #AML and can inform SCT decisions or enrollment into MRD-directed clinical trials. MRD endpo….
0
42
0
RT @BloodAdvances: Geriatric vulnerabilities are frequent among older adults evaluated for CAR-T therapy, enabling risk stratification befo….
0
11
0
RT @MunaQayed: Great to see everyone and to make new friends at the first @AAACTT_org conference. Thank you to our wonderful hosts @KHCFKH….
0
4
0
RT @Eddie_Cliff: Just out @NatureMedicine meta-analysis >7600 CAR T pts led by @DavidCdSMD & @KRejeski . - Non-relapse mortality post CAR-T….
0
90
0
RT @AAACTT_org: AAACTT is cordially inviting you to join us in Amman! Our first conference is coming up in July! Exciting topics from exper….
0
5
0
RT @BloodAdvances: Patients with favorable-risk AML who had NPM1 mutation have poor prognosis if they also harbor mutations highly specific….
0
27
0
RT @AAACTT_org: AAACTT-ing together again in San Antonio. Great evening with colleagues and friends. #Tandem24 #bmtsm .
0
9
0
Orca-T vs “new SOC” PTCy in alloHCT with matched donors and myeloablative regimen. RFS 77% vs 62%, OS 94% vs 77%. Great job @AGomez_MD @WeillCornellBMT #bmtsm
1
1
14
RT @samyamshon: Proud of our amazing fellows and resident @moh7madhomod @joshuaafein and Neela Easwar for sharing our data from @WCMLymphom….
0
9
0
RT @Razan_Mohty: Important questions on sequencing CAR T and Allo in #ALL:.1- Which patients need consolidative Allo after CAR T ?.2- Are r….
0
2
0
RT @Hans_BMTProgram: @niranjankhaire presenting our joint proposal with @NChokr @msorror and @AGomez_MD at the Acute Leukemia Working commi….
0
6
0